Prevalence of childhood asthma and allergies in Serbia and Montenegro
- 104 Downloads
This is the first multi-center epidemiological study on the prevalence of childhood asthma in Serbia and Montenegro. The International Study of Asthma and Allergies in Childhood (ISAAC) phase 3 is a large epidemiological multinational and multicentric study on the prevalence of asthma, allergic rhinitis and eczema in children.
The 12-month period prevalence of asthma, allergic rhinitis and eczema was calculated using an ISAAC phase 3 questionnaire for two age groups: 6–7 years old and 13–14 years old.
In the 13 485 children from five study centers who responded to the questionnaire, the prevalence for childhood asthma ranged from 2.5% to 9.8%, for allergic rhinoconjunctivitis (hay fever) from 4.6% to 21%, and for eczema from 8.2% to 17.2%. The prevalence of current wheezing was high in both age groups (16.5% and 12.4% respectively).
The prevalence of asthma is higher in 6–7 years old school children in the urban and largest cities of Belgrade and Nis, and in 13–14 years old children in Podgorica. The prevalence of asthma, allergic rhinitis and eczema in the school children of Serbia and Montenegro seems similar to that of other countries in Central and South-Eastern Europe.
Key wordsasthma children eczema prevalence rhinitis
Unable to display preview. Download preview PDF.
- 6.Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Resp J 1998;12:315–335.Google Scholar
- 7.Beasley E. The ISSAC programme and the international patterns of asthma prevalence. Handouts of the 58th AAAAI Annual Meeting (Session 3904); 2002 March 1–6; New York City, USA.Google Scholar
- 9.Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225–1232.Google Scholar
- 10.Živkovic Z. Prevalence of childhood asthma, rhinitis and eczema in Belgrade area and Serbia. Deč Pulmol 2002;7:27–43.Google Scholar
- 11.Živanović S, Jovanović-Slavković M, Mileusnić-Milenović R, Perović Lj, Nikolić S, Stojanović-Milojković Lj, et al. Prevalence rate of asthma, rhinitis and eczema in children in Niš. Deč Pulmol 2002;7:45–50.Google Scholar
- 12.Djurica S. Prevalence rate of asthma, rhinitis and eczema in school children of Pancevo. Deč Pulmol 2002;7:57–60.Google Scholar
- 13.Hadnadjev M. Frequency of children’s asthma, allergic rhinitis and eczema in Novi Sad. International studz of asthma and allergies in childhood (phase 3) in Novi Sad. Deč Pulmol 2002;7:51–55.Google Scholar
- 14.Zivkovic Z, Radic S, Smiljanic S, Micic-Stanojevic M, Cerovic S, Jocic-Stojanovic J. Asthma education intervention in children and their parents. Vaiku pulmonologija ir alergologija 2008;11:3756–3765.Google Scholar
- 17.Ellwood P, Asher MI, Beaslez R, Clayton TO, Stewart AW on behalf of the ISSAC Steering Committee and the ISAAC Phase Three Study Group. ISSAC Phase Three Manual. Auckland: ISAAC International Data Centre, 2000.Google Scholar
- 18.Indicators of enviromental health of Republic of Serbia in 2008. www.batut.org.rs (accessed January 14, 2009).Google Scholar
- 22.Vlaski E, Stavric K, Isjanovska R, Kirovski I, Seckova L, Kimovska M, et al. Prevalence rates and risk factors of asthma, hay fever and eczema in schoolchildren in the Republic of Macedonia. Mak Med Pregled 2008;62(Suppl 72):78.Google Scholar
- 24.Aït-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J; ISAAC Phase Three Study Group. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009;64:123–148.CrossRefPubMedGoogle Scholar
- 25.Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK; ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733–743.CrossRefPubMedGoogle Scholar